It should be noted, however, that preliminary results from ongoing trials in patients with metastatic melanoma suggest that the inclusion of antitumor CD4+ T cells in the adoptively transferred T cell population results in poorer clinical responses, which are associated with the expansion of the regulatory T cell compartment [114]. This evidence concerns the gene CD4 and metastatic melanoma.